Long-Term Outcomes and Practical Considerations in the Pharmacological Management of Tyrosinemia Type 1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-Term Outcomes and Practical Considerations in the Pharmacological Management of Tyrosinemia Type 1

Published:2019-10-31 Issue:6 Volume:21 Page:413-426
ISSN:1174-5878
Container-title:Pediatric Drugs
language:en
Short-container-title:Pediatr Drugs

Author:

van Ginkel Willem G.,Rodenburg Iris L.,Harding Cary O.,Hollak Carla E. M.,Heiner-Fokkema M. Rebecca,van Spronsen Francjan J.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/content/pdf/10.1007/s40272-019-00364-4.pdf

Reference176 articles.

1. Baber MD. A case of congenital cirrhosis of the liver with renal tubular defects akin to those in the Fanconi syndrome. Arch Dis Child. 1956;31:335–9.

2. Gentz J, Jagenburg R, Zetterstroem R. Tyrosinemia. J Pediatr. 1965;66:670–96.

3. Kitagawa T. Hepatorenal tyrosinemia. Proc Jpn Acad Ser B Phys Biol Sci. 2012;88:192–200.

4. Lindblad B, Lindstedt S, Steen G. On the enzymic defects in hereditary tyrosinemia. Proc Natl Acad Sci USA. 1977;74:4641–5.

5. van Spronsen FJ, Thomasse Y, Smit GP, Leonard JV, Clayton PT, Fidler V, Berger R, Heymans HS. Hereditary tyrosinemia type I: a new clinical classification with difference in prognosis on dietary treatment. Hepatology. 1994;20:1187–91.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consenso mexicano de tirosinemia tipo 1;Boletín Médico del Hospital Infantil de México;2024-07-13

2. Modified by the Innovative Drugs and Strategies—Pattern of Selected Indications for Pediatric Liver Transplantation;Pediatric Transplantation;2024-07-13

3. Hereditary Tyrosinemia Type-1 With Late Presentation: A Case Report;Cureus;2024-06-23

4. Editorial: Corticosteroids for severe checkpoint inhibitor‐induced liver injury—Not one size fits all?;Alimentary Pharmacology & Therapeutics;2024-03-10

5. Targeted gene delivery through receptors with lipid nanoparticles;Journal of Drug Delivery Science and Technology;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3